These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6184490)

  • 1. Immunotherapy of superficial bladder cancer.
    Shapiro A; Kadmon D; Catalona WJ; Ratliff TL
    J Urol; 1982 Nov; 128(5):891-4. PubMed ID: 6184490
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy of bladder tumors.
    Herr HW
    Uremia Invest; 1984-1985; 8(3-4):257-61. PubMed ID: 6400156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of malignant melanoma.
    Thiers BH
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 1):559-62. PubMed ID: 6176602
    [No Abstract]   [Full Text] [Related]  

  • 4. BCG, levamisole and transfer factor in the treatment of cancer.
    Spitler LE
    Prog Exp Tumor Res; 1980; 25():178-92. PubMed ID: 6986631
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylaxis and therapy of an experimental bladder cancer with biological response modifiers.
    Morales A; Pang AS
    J Urol; 1986 Jan; 135(1):191-3. PubMed ID: 3941461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy in genitourinary neoplasia.
    Droller MJ
    J Urol; 1985 Jan; 133(1):1-5. PubMed ID: 2578065
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy of murine bladder cancer with keyhole limpet hemocyanin (KLH).
    Lamm DL; DeHaven JI; Riggs DR; Ebert RF
    J Urol; 1993 Mar; 149(3):648-52. PubMed ID: 8437283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy of brain tumors].
    Takakura K; Watanabe T
    No Shinkei Geka; 1982 Dec; 10(12):1245-54. PubMed ID: 6188989
    [No Abstract]   [Full Text] [Related]  

  • 9. BCG therapy of superficial bladder tumors.
    Herr HW
    Prog Clin Biol Res; 1989; 303():369-74. PubMed ID: 2674999
    [No Abstract]   [Full Text] [Related]  

  • 10. BCG immunotherapy in superficial cancer of the bladder.
    Levinson IP; van Blerk PJ
    S Afr J Surg; 1985 Jun; 23(2):53-4. PubMed ID: 3895464
    [No Abstract]   [Full Text] [Related]  

  • 11. BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer.
    Debruyne FM; van der Meijden AP; Schreinemachers LM; Geboers AD; Franssen MP; van Leeuwen MJ; Steerenberg PA; de Jong WH; Ruitenberg EJ
    Prog Clin Biol Res; 1988; 269():511-24. PubMed ID: 3134662
    [No Abstract]   [Full Text] [Related]  

  • 12. [Superficial bladder tumors. Preliminary results of a prospective study comparing endovesical BCG, adriamycin and thio-tepa].
    Martínez-Piñeiro JA; de la Peña J; Hidalgo L; Cisneros J; Jiménez León J; Machuca J; Perdices C
    Arch Esp Urol; 1985; 38(6):545-53. PubMed ID: 3938633
    [No Abstract]   [Full Text] [Related]  

  • 13. Quadruple immunotherapy of Bacillus Calmette-Guérin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non-muscle-invasive bladder cancer.
    Steinberg RL; Nepple KG; Velaer KN; Thomas LJ; O'Donnell MA
    Urol Oncol; 2017 Dec; 35(12):670.e7-670.e14. PubMed ID: 28801026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in immunotherapy.
    Krakowka S
    Mod Vet Pract; 1981 Jun; 62(6):447-51. PubMed ID: 6166843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superficial bladder cancer therapy.
    Schenkman E; Lamm DL
    ScientificWorldJournal; 2004 Jun; 4 Suppl 1():387-99. PubMed ID: 15349563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superiority of intravesical immunotherapy with Corynebacterium parvum and Allium sativum in control of murine bladder cancer.
    Marsh CL; Torrey RR; Woolley JL; Barker GR; Lau BH
    J Urol; 1987 Feb; 137(2):359-62. PubMed ID: 3806842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [BCG immunotherapy in the treatment of superficial bladder tumors].
    Samodai L; Drinóczy M; Kolozsy Z; Mohácsi L; Dauda G; Porkoláb Z
    Orv Hetil; 1986 Oct; 127(40):2441-6. PubMed ID: 3537907
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
    Rintala E; Jauhiainen K; Alfthan O
    Prog Clin Biol Res; 1989; 310():271-4. PubMed ID: 2505270
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunotherapy and urological malignancy].
    Marumo K
    Nihon Hinyokika Gakkai Zasshi; 1991 Mar; 82(3):361-71. PubMed ID: 1712869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer.
    Lamm DL; Thor DE; Harris SC; Reyna JA; Stogdill VD; Radwin HM
    J Urol; 1980 Jul; 124(1):38-40. PubMed ID: 6997513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.